Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
about
Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.Inherited biallelic CSF3R mutations in severe congenital neutropenia.The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.Neutrophil disorders and their management.Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death.Neutrophil elastase in cyclic and severe congenital neutropenia.Src family kinases are important negative regulators of G-CSF-dependent granulopoiesisTranscription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cellsNeutropenia in primary immunodeficiencyGenetic and molecular diagnosis of severe congenital neutropenia.Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.Hematopoietic stem cell transplantation for severe congenital neutropenia.Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.Severe congenital neutropenias.Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia.New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.Transit and lifespan in neutrophil production: implications for drug intervention.Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration.Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia.
P2860
Q33729784-66C0F5D7-E308-4230-990E-3B6D1F953077Q33749664-11E64463-EC41-4EB0-B56D-F777D97CBE5DQ33849572-978AE5BC-6046-4D16-B309-7A457ADFE8C3Q34197117-6597B96D-0E6C-4E09-AA95-1309FDABD607Q34477288-264EABA8-E6BD-4DFA-88F0-4D54B7824E98Q34954644-066DE4C2-6A7B-422B-8CEA-E7DB263EE1EFQ35642863-D308A160-C6F4-4FA2-A780-E89330C0A12DQ35849188-408E48F9-3D3F-4761-9DDF-864681F7391FQ36007680-9F441E0B-A554-4282-8D16-96365DCF633DQ37210757-45AB1204-D040-4BF0-98F4-31C15149BBE4Q37287780-C55C48D2-8E5A-4968-B09F-B49E9A66F53BQ37360439-FAF764AF-3EA9-4470-96F8-EE38D6923D74Q37955726-120E6989-A1E0-499B-91BE-1155393D1F29Q38211431-5D0ABE27-6017-45FA-9B77-BB4B40E6DCD0Q39359222-AA6BB1BD-E2C8-4B1C-93CE-C289605820F2Q45192742-BA688765-86CE-44D1-A073-D76B26B2EA2DQ46853118-803B142F-675A-46ED-A8E1-3C1E6ED46381Q47253570-3C48CC39-055E-43AE-BFE2-2D87CD407014Q48180769-B42BE209-A87E-4252-A8E7-1CBC5B8A2031Q54780938-A66BAAB4-1EB6-43BE-A2AE-2155B6069FF9
P2860
Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Novel point mutation in the ex ...... responsive to G-CSF treatment.
@ast
Novel point mutation in the ex ...... responsive to G-CSF treatment.
@en
type
label
Novel point mutation in the ex ...... responsive to G-CSF treatment.
@ast
Novel point mutation in the ex ...... responsive to G-CSF treatment.
@en
prefLabel
Novel point mutation in the ex ...... responsive to G-CSF treatment.
@ast
Novel point mutation in the ex ...... responsive to G-CSF treatment.
@en
P2093
P2860
P356
P1476
Novel point mutation in the ex ...... oresponsive to G-CSF treatment
@en
P2093
A M Schelen
D van Leeuwen
J P de Koning
M H Freedman
Y M van Aesch
P2860
P304
P356
10.1084/JEM.190.4.497
P407
P577
1999-08-01T00:00:00Z